Psychiatr. praxi. 2022;23(2):121-123 | DOI: 10.36290/psy.2022.026

Case study: antidepressants and triptans - is it possible to use them in combination?

PharmDr. Ivana Tašková
Psychiatrická nemocnice Bohnice, Praha; Ústav aplikované farmacie, Farmaceutická fakulta, Masarykova univerzita, Brno

The case report deals with the selection of suitable psychotropic drugs from the group of antidepressants in a patient with anxiety disorder and at the same time suffering from frequent migraine attacks. The interactions of serotonergic antidepressants and triptans (antimigraine drugs) has been widely described in the literature. We deal with concerns from the development of serotonin syndrome, which can be a life-threatening side effect. In practice, there is a need to assess the clinical severity of each drug interaction so that we do not overestimate or underestimate its importance. By incorrect interpretation of the drug interaction, patient can be endangered with side effects or ineffectiveness of therapy. This case study aims to demonstrate the second case described, where the patient was initially undertreated for fear of interaction, which significantly reduced his quality of life.

Keywords: drug interactions, antidepressants, triptans, serotonine syndrome.

Published: June 16, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Tašková I. Case study: antidepressants and triptans - is it possible to use them in combination? Psychiatr. praxi. 2022;23(2):121-123. doi: 10.36290/psy.2022.026.
Download citation

References

  1. Ereshefsky L, Stanford J, Grothe D. Antidepressant Drug­‑Drug Interaction Profile Update. Drugs R D. 2005;6(6):323-336. Go to original source... Go to PubMed...
  2. Lincová D et Farghali H. Základní a aplikovaná farmakologie. 2. vydání. Praha: Galén. 2007. ISBN 978-80-7262-373-0.
  3. Lüllmann H, Mohr K, Wehling M. Farmakologie a toxikologie. Praha: Grada. 2004. ISBN 80-247-0836-1.
  4. Boyer EW. Serotonine syndrome (serotonine toxicity). UpToDate. 2021. Available from: www.uptodate.com
  5. Tašková I et al. Psychofarmaka v kazuistikách. 1. vydání. Praha: Maxdorf Jessenius. 2021. ISBN 978-80-7245-678-8.
  6. Vojtíšek P, Nalos D. Serotoninový syndrom - kazuistika. Anest. intenziv. Med. 2011;22(3):161-2.
  7. Prokeš M, Suchopár J. Serotoninový syndrom: co bychom o něm měli vědět. Medicína pro praxi. 2014;11(5):226-230.
  8. Farmakoterapeutické informace. Serotoninový syndrom. 1/2015. Dostupné na: www.sukl.cz
  9. Mohr P. Serotoninový syndrom - diagnostika, terapie, prevence, Psychiatr. praxi. 2001;3:117-120.
  10. Bouček J, Pidrman V. Psychofarmaka v medicíně. Praha: Grada. 2005. ISBN 80-247-1136-2.
  11. Ritsner SM. Polypharmacy in Psychiatry Practice Volume I. New York: Springer. 2013. Go to original source...
  12. Schwedt TJ, Garza I. Preventive treatment in episodic migraine in adults. UpToDate. 2021. Available from: www.uptodate.com
  13. Orlova Y, et al. Association of Coprescription of Triptan Antimigraine Drugs and Selective Serotonin Reuptake Inhibitor or Selective Norepinephrine Reuptake Inhibitor Antidepressants With Serotonin Syndrome. JAMA Neurol. 2018;75(5):566-572. Go to original source... Go to PubMed...




Psychiatry for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.